Cytarabine Injection interfes with DNA repair and inhibits DNA synthesis. We share glorious credentials in the list of top Manufacturers, Exporters and Suppliers of Cytarabine Injection from Delhi, India. The Cytarabine Injection that we offer is high in demand due to its high effectiveness, longer shelf life and accurate composition.

Indications :

• Induction and maintenance of remission in acute myelocytic leukaemia of both adults & children.
• Acute lymphocytic leukaemia
• Chronic myelocytic leukaemia (Blast Phase)
• Non-Hodgkin's lymphoma
• Meningeal leukaemia
• Malignant pleural effusions
• Multiple Myeloma
• Myelodysplastic syndrome

Dosage :

• Normal adult dosage : Doses of upto 200mg/m2 daily as a continuous IV infusion over 24 hours for 5 days. Total 1000mg/m2.
• Single agent therapy : IV infusion for five days (120 hours) repeated at approximately two weekly intervals.
• Meningeal Leukaemia : Intrathecally 5 mg/m2 to 75 mg/m2 body surface area OD for 4 days to once every 4 days.
• Combination Therapy : 100 to 200 mg/m2 per day by continuous IV infusion (days 1 to 7) or 100 mg/m2 IV every 12 hrs (days 1-7).

Dosage Adjustment :

• Renal Impairment : Not Necessary.
• Hepatic Impairment : Required.

Packing : 500 mg

Cytarabine Injection interfes with DNA repair and inhibits DNA synthesis. We share glorious credentials in the list of top Manufacturers, Exporters and Suppliers of Cytarabine Injection from Delhi, India. The Cytarabine Injection that we offer is high in demand due to its high effectiveness, longer shelf life and accurate composition.

Indications :

• Induction and maintenance of remission in acute myelocytic leukaemia of both adults & children.
• Acute lymphocytic leukaemia
• Chronic myelocytic leukaemia (Blast Phase)
• Non-Hodgkin's lymphoma
• Meningeal leukaemia
• Malignant pleural effusions
• Multiple Myeloma
• Myelodysplastic syndrome

Dosage :

• Normal adult dosage : Doses of upto 200mg/m2 daily as a continuous IV infusion over 24 hours for 5 days. Total 1000mg/m2.
• Single agent therapy : IV infusion for five days (120 hours) repeated at approximately two weekly intervals.
• Meningeal Leukaemia : Intrathecally 5 mg/m2 to 75 mg/m2 body surface area OD for 4 days to once every 4 days.
• Combination Therapy : 100 to 200 mg/m2 per day by continuous IV infusion (days 1 to 7) or 100 mg/m2 IV every 12 hrs (days 1-7).

Dosage Adjustment :

• Renal Impairment : Not Necessary.
• Hepatic Impairment : Required.

Packing : 500 mg